Advancing Diagnosis and Treatment in People Living with HIV and Tuberculosis Meningitis
Purpose of review Tuberculous meningitis (TBM) is the most severe form of tuberculosis. Inadequate diagnostic testing and treatment regimens adapted from pulmonary tuberculosis without consideration of the unique nature of TBM are among the potential drivers. This review focuses on the progress being made in relation to both diagnosis and treatment of TBM, emphasizing promising future directions. Recent findings The molecular assay GeneXpert MTB/Rif Ultra has improved sensitivity but has inadequate negative predictive value to “rule-out” TBM. Evaluations of tests focused on the host response and bacterial components are ongoing. Clinical trials are in progress to explore the roles of rifampin, fluoroquinolones, linezolid, and adjunctive aspirin. Summary Though diagnosis has improved, novel modalities are being explored to improve the rapid diagnosis of TBM. Multiple ongoing clinical trials may change current therapies for TBM in the near future..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
|---|---|
| Enthalten in: |
Current HIV AIDS reports - 20(2023), 6 vom: 10. Nov., Seite 379-393 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kimuda, Sarah [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Central nervous system infection |
|---|
| Anmerkungen: |
© The Author(s) 2023 |
|---|
| doi: |
10.1007/s11904-023-00678-6 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR054073839 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR054073839 | ||
| 003 | DE-627 | ||
| 005 | 20231214064630.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231214s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s11904-023-00678-6 |2 doi | |
| 035 | |a (DE-627)SPR054073839 | ||
| 035 | |a (SPR)s11904-023-00678-6-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kimuda, Sarah |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Advancing Diagnosis and Treatment in People Living with HIV and Tuberculosis Meningitis |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © The Author(s) 2023 | ||
| 520 | |a Purpose of review Tuberculous meningitis (TBM) is the most severe form of tuberculosis. Inadequate diagnostic testing and treatment regimens adapted from pulmonary tuberculosis without consideration of the unique nature of TBM are among the potential drivers. This review focuses on the progress being made in relation to both diagnosis and treatment of TBM, emphasizing promising future directions. Recent findings The molecular assay GeneXpert MTB/Rif Ultra has improved sensitivity but has inadequate negative predictive value to “rule-out” TBM. Evaluations of tests focused on the host response and bacterial components are ongoing. Clinical trials are in progress to explore the roles of rifampin, fluoroquinolones, linezolid, and adjunctive aspirin. Summary Though diagnosis has improved, novel modalities are being explored to improve the rapid diagnosis of TBM. Multiple ongoing clinical trials may change current therapies for TBM in the near future. | ||
| 650 | 4 | |a Tuberculous meningitis |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Tuberculosis |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a TB |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Diagnostic tests |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Central nervous system infection |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Kasozi, Derrick |4 aut | |
| 700 | 1 | |a Namombwe, Suzan |4 aut | |
| 700 | 1 | |a Gakuru, Jane |4 aut | |
| 700 | 1 | |a Mugabi, Timothy |4 aut | |
| 700 | 1 | |a Kagimu, Enock |4 aut | |
| 700 | 1 | |a Rutakingirwa, Morris K. |4 aut | |
| 700 | 1 | |a Leon, Kristoffer E. |4 aut | |
| 700 | 1 | |a Chow, Felicia |4 aut | |
| 700 | 1 | |a Wasserman, Sean |4 aut | |
| 700 | 1 | |a Boulware, David R. |4 aut | |
| 700 | 1 | |a Cresswell, Fiona V. |4 aut | |
| 700 | 1 | |a Bahr, Nathan C. |0 (orcid)0000-0002-9431-8938 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current HIV AIDS reports |d Philadelphia, Pa. : Current Science, 2004 |g 20(2023), 6 vom: 10. Nov., Seite 379-393 |w (DE-627)SPR022938354 |w (DE-600)2179699-3 |x 1548-3576 |7 nnns |
| 773 | 1 | 8 | |g volume:20 |g year:2023 |g number:6 |g day:10 |g month:11 |g pages:379-393 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s11904-023-00678-6 |z kostenfrei |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 951 | |a AR | ||
| 952 | |d 20 |j 2023 |e 6 |b 10 |c 11 |h 379-393 | ||